Effective in vivo purging with rituximab and autologous peripheral blood stem cell transplantation in a woman with CD5 positive primary cutaneous diffuse large B-cell lymphoma

European Journal of Haematology

Volumn 74, Issue 6, 2005, Pages 526-528

  Goto, H ^a   Nishio, Mitsufumi ^a   Endo, T ^a   Sato, N ^b   Koizumi, K ^a   Fujimoto, K ^a   Sakai, T ^a   Kumano, K ^a   Obara, M ^a   Koike, T ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

APBSCT; CD5+ diffuse large B cell lymphoma; In vivo purging; Primary cutaneous B cell lymphoma; Rituximab

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CD20 ANTIGEN; CD5 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; RANIMUSTINE; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CANCER REGRESSION; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; JAPAN; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; TREATMENT INDICATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD5; ANTINEOPLASTIC AGENTS; BONE MARROW; BONE MARROW PURGING; FEMALE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REMISSION INDUCTION; SKIN NEOPLASMS; TRANSPLANTATION, AUTOLOGOUS;

EID: 21044455448     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00414.x     Document Type: Article

References (15)

1. YAMAGUCHI M, SETO M, OKAMOTO M, et al. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood 2002;99:815-821.
2. YAMAGUCHI M, OHNO T, OKA K, TANIGUCHI M, ITO M, KITA K, SHIKU H. De novo CD5-positive diffuse large B-cell lymphoma: clinical characteristics and therapeutic outcome. Br J Haematol 1999;105:1133-1139.
3. KERL H, KODAMA K, CERRONI L. Diagnostic principles and new developments in primary cutaneous B-cell lymphomas. J Dermatol Sci 2004;34:167-175.
4. GOODLAD JR, KRAJEWSKI AS, BATSTONE PJ, MCKAY P, WHITE JM, BENTON EC, KAVANAGH GM, LUCRAFT HH. Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes. Am J Surg Pathol 2003;27:1538-1545.
5. ENDO T, SATO N, MOGI Y, KOIZUMI K, NISHIO M, FUJIMOTO K, SAKAI T, KUMANO K, OBARA M, IKEDA H, KOIKE T. Peripheral blood stem cell mobilization following CHOP plus rituximab therapy combined with G-CSF in patients with B-cell non-Hodgkin's lymphoma. Bone Marrow Transplant 2004;33:703-707.
6. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987-994.
7. MCKELVEY EM, GOTTLIEB JA, WILSON HE, et al. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer 1976;38:1484-1493.
8. TAKAHASHI T, KAZAMA Y, SHIMIZU H, YOSHIMOTO M, TSUJISAKI M, IMAI K. De novo CD5-positive diffuse large B cell lymphoma solely presenting as multiple subcutaneous nodules. Acta Haematol 2002;107:230-233.
9. TANAKA M, ICHINOHASAMA R, IWASAKI M, SATO M, TAGAMI H. Primary cutaneous B-cell lymphomas in Japan. A report of three cases and a comparison of Japanese and white patients. J Am Acad Dermatol 1994;31:54-60.
10. HEMBURY TA, LEE B, GASCOYNE RD, MACPHERSON N, YANG B, HOUSE N, MEDEIROS LJ, HSI ED. Primary cutaneous diffuse large B-cell lymphoma: a clinicopathologic study of 15 cases. Am J Clin Pathol 2002;117:574-580.
11. - diffuse large B-cell lymphomas. Cancer Res 2003;63:60-66.
12. GRIBBEN JG, NEUBERG D, FREEDMAN AS, GIMMI CD, PESEK KW, BARBER M, SAPORITO L, WOO SD, CORAL F, SPECTOR N, et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993;81:3449-3457.
13. FREEDMAN AS, GRIBBEN JG, NEUBERG D, et al. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood 1996;88:2780-2786.
14. ARCAINI L, ORLANDI E, ALESSANDRINO EP, et al. A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma. Bone Marrow Transplant 2004;34:175-179.
15. GIANNI AM, MAGNI M. MARTELLI M, et al. Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen). Blood 2003;102:749-755.